Artificial intelligence×Bioinformatics
This pair ranks in the top 0.1% of every collision candidate in the corpus. Across held-out years, pairs scoring that well went on to co-publish at 10.0× the base rate, typically within 2 years.
The Frontier Brief for this collision is still being written. The evidence below already reflects the current model run.
Pre-company space. No named players have staked this collision yet — an emerging pairing where the field, not a firm, is the story so far.
16 researchers publish on both sides of this collision without the fields themselves having met. Every name below is counted from papers in the corpus — not inferred.
- Yang ZhangZhejiang University of Technology4/1
- Wei ZhengZhejiang University of Technology2/1
- Chengxin ZhangZhejiang University of Technology2/1
- Martin SteineggerSynlab Czech (Czechia)2/1
- Yang LiMichigan Medicine2/1
- Robin PearceMichigan Medicine2/1
- Guijun ZhangZhejiang University of Technology2/1
- Xiaogen ZhouZhejiang University of Technology2/1
- Charles‐Antoine DutertreSingHealth Duke-NUS Academic Medical Centre1/1
- Eric W. BellMichigan Medicine1/1
- Harvard UniversityUS144/63
- Stanford UniversityUS279/18
- Massachusetts Institute of TechnologyUS193/26
- University of CambridgeGB126/35
- University College LondonGB125/35
- ETH ZurichCH125/28
- CPC2: a fast and accurate coding potential calculator based on sequence intrinsic features2017 · 1,821 citations · DOI ↗2
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens2019 · 1,454 citations · DOI ↗2
- Advances in the delivery of RNA therapeutics: from concept to clinical reality2017 · 650 citations · DOI ↗2
- DeepCRISPR: optimized CRISPR guide RNA design by deep learning2018 · 633 citations · DOI ↗2
Counted from the corpus. Institution counts use best-effort affiliation (every author on a paper is paired with every institution on it), so read them as presence, not headcount.
A premium Deep-Dive is being generated for this collision — check back soon.